Unknown

Dataset Information

0

Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine.

ABSTRACT:

SUBMITTER: Lassauniere R 

PROVIDER: S-EPMC9107029 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine.

Lassaunière Ria R   Polacek Charlotta C   Frische Anders A   Boding Lasse L   Sækmose Susanne Gjørup SG   Rasmussen Morten M   Fomsgaard Anders A  

JAMA network open 20220502 5

Similar Datasets

Unknown Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave.
| S-EPMC9867771 | biostudies-literature
Unknown Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease.
| S-EPMC10533557 | biostudies-literature
Unknown Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine.
| S-EPMC9225806 | biostudies-literature
Unknown Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination.
| S-EPMC8940714 | biostudies-literature
Unknown Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies.
| S-EPMC9540141 | biostudies-literature
Unknown Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies.
| S-EPMC9681044 | biostudies-literature
Unknown Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.
| S-EPMC9926440 | biostudies-literature
Unknown Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees.
| S-EPMC9189263 | biostudies-literature
Unknown Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5.
| S-EPMC10101054 | biostudies-literature
Unknown Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination.
| S-EPMC9394243 | biostudies-literature